| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crispr Therapeutics AG (CRSP) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. CRSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $13.89M | - | |
| Dir | 22.0K | $1.20M | - | |
| CFO | 19.5K | $1.06M | - | |
| Other | 19.4K | $1.05M | -3,786 | |
| Other | 17.0K | $924.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 26, 2020 | Ho Tony W | Executive VP, Head Of R&D | Sell | 6,700 | $70.13 | $469,884.00 | -7.1% | |
| May 20, 2020 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 15,000 | $65.25 | $978,683.16 | -4.2% | |
| May 19, 2020 | Novak Rodger75 | President | Sell | 50,000 | $65.00 | $3,250,000.00 | -5.9% | |
| May 11, 2020 | Klein Lawrence Otto | Cbo &COO | Sale+OE | 25,000 | $60.40 | $1,509,970.58 | -38.1% | |
| Nov 19, 2019 | Bolzon Bradley J Phd75 | Director | Sell | 42,000 | $67.41 | $2,831,388.00 | -6.6% | |
| Nov 19, 2019 | Novak Rodger75 | President | Sale+OE | 33,618 | $70.00 | $2,353,260.00 | -100% | |
| Nov 19, 2019 | Cagnoni Pablo J | Director | Sale+OE | 7,500 | $62.00 | $465,000.00 | -100% | |
| Nov 12, 2019 | Cagnoni Pablo J | Director | Sale+OE | 7,500 | $55.00 | $412,500.00 | -100% | |
| Oct 30, 2019 | Cagnoni Pablo J | Director | Sale+OE | 7,500 | $52.00 | $390,000.00 | -100% | |
| Oct 30, 2019 | Bolzon Bradley J Phd75 | Director | Sell | 21,000 | $51.89 | $1,089,675.30 | -60.4% |